Clinical trial
Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial
NCT00476619 · Brigham and Women's Hospital, Other · Terminated
Key facts
| NCT number | NCT00476619 |
|---|---|
| Title | Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial |
| Official title | Erythropoietin in Radiocontrast Induced Nephropathy (ERIN) Trial |
| Acronym | ERIN |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | Ortho Biotech Products, L.P. Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Contrast Induced Nephropathy |
| Intervention type | Drug |
| Interventions | erythropoeitin |
| Enrollment | 17 |
| Start date | Sep 1, 2004 |
| Primary completion | Nov 1, 2007 |
| Completion | Jun 1, 2008 |
| First posted | May 22, 2007 |
| Last update posted | Apr 6, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: